Kevin Patrick Stellish is a pharmacist who is specialized in Oncology in Denver, Colorado. Patients can reach him at 2045 N Franklin St, Denver or contact him on 303-548-3795. Active license number of Kevin Patrick Stellish is 0018413 for Oncology in Colorado. Kevin Patrick Stellish is a licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.
Complete Profile:
Kevin Patrick Stellish speciality, credentials, practice address, contact phone number and fax are as below. Patients can call on the below given phone number for enquiries.
Name:
Kevin Patrick Stellish
Specialization:
Oncology
Credentials:
PHARMD
Gender:
Male
Location:
2045 N Franklin St, Denver, Colorado, 80205-5437
Phone:
303-548-3795
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details of Kevin Patrick Stellish are as mentioned below.
NPI Number:
1306627153
NPI Enumeration Date:
09 Oct, 2023
NPI Last Update On:
09 Oct, 2023
Medical Licenses:
Pharmacists can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Kevin Patrick Stellish are as mentioned below.
Specialization
License Number
State
Status
Oncology
0018413
Colorado
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
2045 N Franklin St, Denver, Colorado
Zip:
80205-5437
Phone Number:
--
Fax Number:
--
Patients can reach Kevin Patrick Stellish at 2045 N Franklin St, Denver, Colorado or can call on phone at 303-548-3795.
Comments/ Reviews:
*Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 09 December, 2024.